These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9639806

  • 21. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D, Szprynger K.
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [Abstract] [Full Text] [Related]

  • 22. Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
    Gault MH, Longerich LL, Purchase L, Harnett J, Breckenridge C.
    Nephron; 1995; 70(2):155-70. PubMed ID: 7566298
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients.
    Schreier L, González AI, Elbert A, Berg G, Wikinski R.
    Metabolism; 2004 Aug; 53(8):1013-5. PubMed ID: 15281010
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T, Miyamae M, Tomonaga O, Omori Y.
    Adv Perit Dial; 1996 Aug; 12():120-5. PubMed ID: 8865885
    [Abstract] [Full Text] [Related]

  • 27. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J, Janicka L, Ksaziek A, Janicki K.
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [Abstract] [Full Text] [Related]

  • 28. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, Ootsuka S, Shinoda T, Yanagi H, Tsuchiya S, Marumo F.
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [Abstract] [Full Text] [Related]

  • 29. Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uremic patients treated by hemodialysis.
    Robert D, Jeanmonod R, Favre H, Fruchart JC, Sturzenegger E, Riesen W.
    Metabolism; 1989 Jun; 38(6):514-21. PubMed ID: 2498613
    [Abstract] [Full Text] [Related]

  • 30. Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.
    Hörkkö S, Huttunen K, Läärä E, Kervinen K, Kesäniemi YA.
    Ann Med; 1994 Aug; 26(4):271-82. PubMed ID: 7946245
    [Abstract] [Full Text] [Related]

  • 31. Alterations in lipoprotein composition in peritoneal dialysis patients.
    Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson C, Alaupovic P.
    Perit Dial Int; 2002 Aug; 22(2):220-8. PubMed ID: 11990407
    [Abstract] [Full Text] [Related]

  • 32. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Vanichakarn S, Nimmannit S, Chirawong P, Ong-Ajyooth S, Nilwarangkur S.
    Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [Abstract] [Full Text] [Related]

  • 34. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
    Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H.
    Metabolism; 1991 Oct; 40(10):1002-8. PubMed ID: 1943724
    [Abstract] [Full Text] [Related]

  • 35. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.
    Chan MK.
    Metabolism; 1989 Oct; 38(10):939-45. PubMed ID: 2507877
    [Abstract] [Full Text] [Related]

  • 36. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
    Kim SB, Yang WS, Kang ES, Min WK, Park JS.
    Perit Dial Int; 1997 Oct; 17(3):236-42. PubMed ID: 9237283
    [Abstract] [Full Text] [Related]

  • 37. Influence of apolipoprotein E genotype on lipid and lipoprotein levels in continuous ambulatory peritoneal dialysis patients.
    Choi KH, Song HY, Shin SK, Noh H, Kang SW, Kim JH, Lee HY, Han DS.
    Adv Perit Dial; 1999 Oct; 15():243-6. PubMed ID: 10682111
    [Abstract] [Full Text] [Related]

  • 38. Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis.
    Kaysen GA, Dalrymple LS, Grimes B, Chertow GM, Kornak J, Johansen KL.
    Nephrol Dial Transplant; 2014 Feb; 29(2):430-7. PubMed ID: 24009290
    [Abstract] [Full Text] [Related]

  • 39. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.
    Henkin Y, Neeman Z, Zuili I, Chaimovitz C, Shany S.
    Am J Kidney Dis; 1993 Dec; 22(6):829-34. PubMed ID: 8250029
    [Abstract] [Full Text] [Related]

  • 40. Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern.
    Arnadottir M, Dallongeville J, Nilsson-Ehle P, Berg AL.
    Scand J Clin Lab Invest; 2001 Jul; 61(4):301-6. PubMed ID: 11465344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.